Showing 81 - 100 results of 2,687 for search '"chemotherapy"', query time: 0.08s Refine Results
  1. 81
  2. 82
  3. 83

    Patient-Tailored, Imaging-Guided, Long-Term Temozolomide Chemotherapy in Patients with Glioblastoma by Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Roland T. Ullrich, Heiko Backes, Anna Brunn, Wolf-Dieter Heiss, Andreas H. Jacobs

    Published 2010-01-01
    “…We present two patients with glioblastoma with an unusually stable clinical course and long-term survival who were treated after surgery and radiotherapy with adjuvant temozolomide (TMZ) chemotherapy for 17 and 20 cycles, respectively. Afterward, adjuvant TMZ chemotherapy was discontinued in one patient and the dosage of TMZ was reduced in the other. …”
    Get full text
    Article
  4. 84
  5. 85
  6. 86

    Genetic Variations Affect Chemotherapy Outcomes: A Role of the Spindle-assembly Checkpoint by Sinjini Sarkar, Ranita Pal, Trisha Choudhury, Manisha Vernekar, Partha Nath, Vilas D. Nasare

    Published 2024-04-01
    “…This study investigated a SAC component, Budding Uninhibited by Benzimidazoles 3 (BUB3), its expression, and genetic variants in advanced ovarian cancer patients treated with paclitaxel–carboplatin chemotherapy. Among 80 patients, BUB3 expression correlated with chemosensitivity, suggesting its potential as a predictive marker for chemotherapy response. …”
    Get full text
    Article
  7. 87

    Comparing Health-Related Quality of Life of Cancer Patients under Chemotherapy and of Their Caregivers by Ioannis Vrettos, Konstantinos Kamposioras, Nick Kontodimopoulos, Evelina Pappa, Elissavet Georgiadou, Dionysios Haritos, Angelos A. Papadopoulos, Dimitris Niakas

    Published 2012-01-01
    “…Quality of life is highly influenced during the period of chemotherapy for both patients and caregivers and is often under reported. …”
    Get full text
    Article
  8. 88

    A Case of Unresectable Papillary Thyroid Carcinoma Treated with Lenvatinib as Neoadjuvant Chemotherapy by Hiroyuki Iwasaki, Soji Toda, Hiroyuki Ito, Daiji Nemoto, Daisuke Murayama, Yoichiro Okubo, Hiroyuki Hayashi, Tomoyuki Yokose

    Published 2020-01-01
    “…This case is reported as a successful case of neoadjuvant chemotherapy and interval debulking surgery.…”
    Get full text
    Article
  9. 89
  10. 90
  11. 91

    Cytogenetically Unrelated Clones in Acute Myeloid Leukemia Showing Different Responses to Chemotherapy by Kohei Kasahara, Masahiro Onozawa, Naohiro Miyashita, Emi Yokohata, Miho Yoshida, Minoru Kanaya, Mizuha Kosugi-Kanaya, Ryo Takemura, Shojiro Takahashi, Junichi Sugita, Akio Shigematsu, Mutsumi Takahata, Shinichi Fujisawa, Daigo Hashimoto, Katsuya Fujimoto, Tomoyuki Endo, Takeshi Kondo, Takanori Teshima

    Published 2016-01-01
    “…We concluded that one clone was de novo AMoL with chromosome 6, 8, 11, 13, and 19 trisomy and that the other was acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) with chromosome 7 monosomy showing different responses to chemotherapy. Simultaneous onset of cytogenetically unrelated hematological malignancies that each have a different disease status is a rare phenomenon but is important to diagnose for a correct understanding of the disease status and for establishing an appropriate treatment strategy.…”
    Get full text
    Article
  12. 92
  13. 93

    Transketolase attenuates the chemotherapy sensitivity of glioma cells by modulating R-loop formation by Minjie Fu, Mengli Zhang, Licheng Zhang, Yuan Feng, Chao Gao, Hao Xu, Jinsen Zhang, Huaichao Zhang, Tianping Peng, Youjun Chu, Yonghe Wu, Pu Wang, Dan Ye, Ying Mao, Wei Hua

    Published 2025-01-01
    “…Depletion of TKT leads to increased R-loop accumulation and genome instability, increasing the susceptibility of glioma cells to chemotherapy. In conclusion, our study reveals a non-metabolic function of TKT in regulating R-loop dynamics, genome instability, and chemotherapy sensitivity in gliomas.…”
    Get full text
    Article
  14. 94

    Intra-Arterial Chemotherapy with Doxorubicin and Cisplatin Is Effective for Advanced Hepatocellular Cell Carcinoma by Ming-Chun Ma, Yen-Yang Chen, Shau-Hsuan Li, Yu-Fan Cheng, Chih-Chi Wang, Tai-Jan Chiu, Sung-Nan Pei, Chien-Ting Liu, Tai-Lin Huang, Chen-Hua Huang, Yu-Li Su, Yen-Hao Chen, Sheng-Nan Lu, Kun-Ming Rau

    Published 2014-01-01
    “…Advanced hepatocellular carcinoma (HCC) remains a fatal disease even in the era of targeted therapies. Intra-arterial chemotherapy (IACT) can provide therapeutic benefits for patients with locally advanced HCC who are not eligible for local therapies or are refractory to targeted therapies. …”
    Get full text
    Article
  15. 95
  16. 96

    Sulforaphane in alternative cancer chemotherapy: From carcinogenesis suppression to drug resistance reversal by Seyed Mohammad Doodmani, Payman Rahimzadeh, Najma Farahani, Seyedalireza Mirilavasani, Mina Alimohammadi, Noushin Nabavi, Elmira Alaei, Afshin Taheriazam, Maryam Abedi, Nadia Shafiee, Salman Daneshi, Mehrdad Hashemi

    Published 2025-01-01
    “…The management and treatment of cancer have posed significant challenges in recent years. Conventional chemotherapy, despite its widespread use, has encountered obstacles such as the emergence of drug resistance. …”
    Get full text
    Article
  17. 97

    G-CSF-Associated Bone Marrow Necrosis in AML after Induction Chemotherapy by Ikenna Osuorji, Lyle Goldman

    Published 2012-01-01
    “…We report a case of 66-year-old male with AML-M4 (FAB classification) who was given induction chemotherapy with cytarabine and daunorubicin. Filgrastim at 480 micrograms was administered on days 15–19 to shorten the duration of neutropenia. …”
    Get full text
    Article
  18. 98

    Complete Disappearance of Choroidal Metastasis from Lung Adenocarcinoma Treated with Bevacizumab and Chemotherapy by Hampig Raphael Kourie, Joelle Antoun, Alexandre Schakal, Elie Nasr, Marwan Sahyoun, Joseph Kattan

    Published 2015-01-01
    “…This case report demonstrates the importance of the systemic bevacizumab and chemotherapy in the treatment of choroidal metastasis from adenocarcinoma of the lung.…”
    Get full text
    Article
  19. 99

    Dynamics of a Breast Cancer Model for Neutropenia Case due to Chemotherapy Effects by M. Ivan Ariful Fathoni, Fajar Adi-Kusumo, Gunardi Gunardi, Susanna Hilda Hutajulu

    Published 2021-01-01
    “…The neutrophil is one of the cells that is influenced by chemotherapy drugs. Chemotherapy-induced neutropenia is one of the most common toxic effects experienced by patients and often threatens chemotherapy to use efficiency. …”
    Get full text
    Article
  20. 100

    Application and Effect of the Gymnastic Exercise Mode during Chemotherapy for Breast Cancer Patients by Feifei Xie

    Published 2020-01-01
    “…In the past ten years, the incidence rate of breast cancer in China’s major cities has increased by 37%, far higher than that in Europe and America. At present, chemotherapy and radiotherapy are the main treatment methods for breast cancer, but many patients will have cancer-related fatigue after surgery. …”
    Get full text
    Article